Silo Pharma, Inc. (SILO)
NASDAQ: SILO · Real-Time Price · USD
0.341
+0.013 (3.91%)
At close: Mar 9, 2026, 4:00 PM EDT
0.349
+0.009 (2.58%)
After-hours: Mar 9, 2026, 7:37 PM EDT
Silo Pharma Revenue
Silo Pharma had revenue of $18.03K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $72.10K. In the year 2024, Silo Pharma had annual revenue of $72.10K.
Revenue (ttm)
$72.10K
Revenue Growth
n/a
P/S Ratio
62.90
Revenue / Employee
$24,034
Employees
3
Market Cap
4.53M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSILO News
- 14 days ago - Silo Pharma Announces Share Buyback Program - GlobeNewsWire
- 19 days ago - Silo Pharma Receives Notice of Allowance in Japan for SPC-15, Expanding Global Intellectual Property Portfolio - GlobeNewsWire
- 2 months ago - Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15 - GlobeNewsWire
- 4 months ago - Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD - GlobeNewsWire
- 4 months ago - Silo Pharma Selects Alphaledger's T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain - GlobeNewsWire
- 4 months ago - Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program - GlobeNewsWire
- 5 months ago - Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company's Commitment to Multi-Chain Growth - GlobeNewsWire
- 5 months ago - Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci) - GlobeNewsWire